2000 SIERRA POINT PARKWAY, BRISBANE, CA
Financial Results, Press Release
News, Securities Holder Rights or Indentures, Material Contracts
Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
Investor Presentation
Tempest Therapeutics Acquires CAR T-Cell Therapy Assets from Erigen LLC
Material disclosure
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Annual Report to Security Holders
FY 2025
Q3
Q2
Q1
Amended Annual Report
FY 2024
Notice of Exempt Offering of Securities
Registration Statement for Securities Offered under a Shelf Registration
Effectiveness Notice
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
S-8 POS
Correspondence
Submission Upload